Home » Topics » Regulatory » EMA

EMA
RSS

EMA's CHMP recommends approval of Gazyvaro for previously untreated advanced follicular lymphoma

July 24, 2017

CHMP issues negative opinion on Vanda Pharmaceuticals' Fanaptum

July 24, 2017

CHMP recommends approval of avelumab for metastatic Merkel cell carcinoma

July 24, 2017

Xermelo obtains positive opinion from EMA committee

July 24, 2017

CHMP supports approval of Novartis' Rydapt in E.U.

July 24, 2017

Lutathera receives positive opinion from EMA for GEP-NETs

July 24, 2017

AbbVie's Humira receives positive opinion from EMA for uveitis

July 24, 2017

EMA committee backs approval of Janssen's Symtuza

July 24, 2017

EMA's CHMP grants positive opinion for dupixent for the treatment of atopic dermatitis

July 24, 2017

EMA committee recommends approval of label update for Lixiana

July 17, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...